Sanford C. Bernstein Analysts Give Sanofi SA (SAN) a €75.00 Price Target
Sanofi SA (EPA:SAN) received a €75.00 ($82.42) price objective from investment analysts at Sanford C. Bernstein in a research note issued to investors on Wednesday. The firm presently has a a “neutral” rating on the stock.
SAN has been the topic of several other reports. JPMorgan Chase & Co. reaffirmed a “sell” rating on shares of Sanofi SA in a research report on Tuesday, October 4th. BNP Paribas set a €78.00 ($85.71) price target on Sanofi SA and gave the company a “neutral” rating in a report on Wednesday, September 14th. Jefferies Group set a €74.00 ($81.32) price target on Sanofi SA and gave the company a “neutral” rating in a report on Thursday, October 13th. Deutsche Bank AG set a €95.00 ($104.40) price target on Sanofi SA and gave the company a “buy” rating in a report on Thursday, October 13th. Finally, Independent Research GmbH set a €77.00 ($84.62) price target on Sanofi SA and gave the company a “neutral” rating in a report on Thursday, June 30th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the company’s stock. Sanofi SA has a consensus rating of “Hold” and a consensus price target of €85.24 ($93.67).
Sanofi SA (EPA:SAN) traded down 0.36% during midday trading on Wednesday, hitting €68.61. 753,983 shares of the company traded hands. Sanofi SA has a 12-month low of €22.81 and a 12-month high of €68.79. The stock has a 50 day moving average of €25.91 and a 200 day moving average of €25.76. The stock has a market cap of €88.30 billion and a P/E ratio of 21.33.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/19/sanford-c-bernstein-analysts-give-sanofi-sa-san-a-75-00-price-target.html
About Sanofi SA
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.